Ethambutol, a cell wall inhibitor of Mycobacterium tuberculosis, elicits l-glutamate efflux of Corynebacterium glutamicum

  • Eva Radmacher
    Institute for Biotechnology, Research Centre Jülich, D-52425 Jülich, Germany
  • Kathrin C. Stansen
    Institute for Biotechnology, Research Centre Jülich, D-52425 Jülich, Germany
  • Gurdyal S. Besra
    School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK
  • Luke J. Alderwick
    School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK
  • William N. Maughan
    School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK
  • Günter Hollweg
    Pathology, University Hospital, D-52074 Aachen, Germany
  • Hermann Sahm
    Institute for Biotechnology, Research Centre Jülich, D-52425 Jülich, Germany
  • Volker F. Wendisch
    Institute for Biotechnology, Research Centre Jülich, D-52425 Jülich, Germany
  • Lothar Eggeling
    Institute for Biotechnology, Research Centre Jülich, D-52425 Jülich, Germany

抄録

<jats:p> <jats:italic>Corynebacterium glutamicum</jats:italic> is used for the large-scale production of <jats:sc>l</jats:sc>-glutamate, but the efflux of this amino acid is poorly understood. This study shows that addition of ethambutol (EMB) to growing cultures of <jats:italic>C. glutamicum</jats:italic> causes <jats:sc>l</jats:sc>-glutamate efflux at rates of up to 15 nmol min<jats:sup>−1</jats:sup> (mg dry wt)<jats:sup>−1</jats:sup>, whereas in the absence of EMB, no efflux occurs. EMB is used for the treatment of <jats:italic>Mycobacterium tuberculosis</jats:italic>, and at a molecular level it targets a series of arabinosyltransferases (EmbCAB). The single arabinosyltransferase-encoding <jats:italic>emb</jats:italic> gene of <jats:italic>C. glutamicum</jats:italic> was placed under the control of a Tet repressor (TetR). Experiments with this strain, as well as with an <jats:italic>emb</jats:italic>-overexpressing strain, coupled with biochemical analyses showed that: (i) <jats:italic>emb</jats:italic> expression was correlated with <jats:sc>l</jats:sc>-glutamate efflux, (ii) <jats:italic>emb</jats:italic> overexpression increased EMB resistance, (iii) EMB caused less arabinan deposition in cell wall arabinogalactan, and (iv) EMB caused a reduced content of cell-wall-bound mycolic acids. Thus EMB addition resulted in a marked disordering of the cell envelope, which was also discernible by examining cellular morphology. In order to further characterize the cellular response to EMB addition, genome-wide expression profiling was performed using DNA microarrays. This identified 76 differentially expressed genes, with 18 of them upregulated more than eightfold. Among these were the cell-wall-related genes <jats:italic>ftsE</jats:italic> and <jats:italic>mepA</jats:italic> (encoding a secreted metalloprotease); however, genes of central metabolism were largely absent. Given that an altered lipid composition of the plasma membrane of <jats:italic>C. glutamicum</jats:italic> can result in <jats:sc>l</jats:sc>-glutamate efflux, we speculate that major structural alterations of the cell envelope are transmitted to the membrane, which in turn activates an export system, perhaps via increased membrane tension.</jats:p>

収録刊行物

  • Microbiology

    Microbiology 151 (5), 1359-1368, 2005-05-01

    Microbiology Society

被引用文献 (8)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ